| Literature DB >> 29315277 |
Mohammad Rizwan1, Noor Faizah Mohd-Naim2,3, Minhaz Uddin Ahmed4.
Abstract
The rapid and increasing use of the nanomaterials (NMs), nanostructured materials (NSMs), metal nanoclusters (MNCs) or nanocomposites (NCs) in the development of electrochemiluminescence (ECL) nanobiosensors is a significant area of study for its massive potential in the practical application of nanobiosensor fabrication. Recently, NMs or NSMs (such as AuNPs, AgNPs, Fe₃O₄, CdS QDs, OMCs, graphene, CNTs and fullerenes) or MNCs (such as Au, Ag, and Pt) or NCs of both metallic and non-metallic origin are being employed for various purposes in the construction of biosensors. In this review, we have selected recently published articles (from 2014-2017) on the current development and prospects of label-free or direct ECL nanobiosensors that incorporate NCs, NMs, NSMs or MNCs.Entities:
Keywords: electrochemiluminescence; label-free; metal nanoclusters; nanobiosensors; nanocomposites; nanomaterials; nanostructure materials; ordered mesoporous carbon; signal amplification
Mesh:
Substances:
Year: 2018 PMID: 29315277 PMCID: PMC5795924 DOI: 10.3390/s18010166
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Number of articles published on ECL biosensors in the last 10 years with the keyword search of “electrochemiluminescence biosensor”, either in the title or in the abstract [26].
Figure 2Illustrated scheme of a biosensor and its fundamental components.
Figure 3Research articles published in the last 10 years with the following keyword search: (A) “biosensor using adsorption,” (B) “biosensor using encapsulation,” (C) “biosensor using crosslinking” and (D) “biosensor using covalent bonding”, either in the title or in the abstract [26].
Figure 4Illustrated scheme of event when physically adsorbing biomolecules on the surface of (A) transducer; (B) nanocomposites-modified transducer; (C) covalently attaching biorecognition elements on the transducer; (D) crosslinking between biorecognition elements and the transducer; and (E) biorecognition elements entrapment in polymer matrix.
Types of biosensor based on transducers/signals transduced.
| Signal Type on Transducer | Signal Transduced | Type of Biosensors | Reference |
|---|---|---|---|
| Electrical | Electrochemical | [ | |
| Electrical | Optical | [ | |
| Electrical | Piezoelectric | [ | |
| Electrical | Thermal | [ |
Figure 5Schematic illustration of ECL mechanism and its generation on electrode surface in presence of suitable luminophore and co-reactant.
Scheme 1Ion annihilation pathways.
Scheme 2Oxidative-reduction co-reactant ECL pathways.
Scheme 3Reductive-oxidation co-reactant ECL pathways. Here, *Cr and *Co are the co-reactant intermediates for the reducing and oxidizing agents, respectively, and P is the product associated with *Cr and *Co reactions, h is the Planck constant with a value of 6.634 × 10−34 J.s or 4.13 × 10−15 ev, v is the frequency (Hz) of the emitted light (v = c/λ, c = speed of light (3.00 × 108 ms−1), and λ is wavelength of the emitted light).
Figure 6Illustration of various nanostructure materials or nanomaterials or metal nanocluster or nanocomposite being used for the fabrication of ECL nanobiosensors (MNPs: Magnetic nanoparticles, CNOs: Carbon nano-onions, GR: Graphene, BNPs: Bimetallic nanoparticles, CNFs: Carbon nanofiber, CNTs: Carbon nanotubes, QDs: Quantum dots, NPs: Nanoparticles).
Metals- and magnetic-NMs- or NSMs- or MNCs- or NCs-based ECL nanobiosensors.
| Electrode | NMs/NSMs | NCs | Function | Assay type | Bioanalyte | LOD | Range | Ref. |
|---|---|---|---|---|---|---|---|---|
| GCE | AuNPs | MWCNTs-Cys-AuNPs | Signal amplification, reproducibility, high sensitivity, stability and cost-effective | Direct | Diphen-hydramine hydrochloride (DPH) | 6.7 × 10−9 M | 2 × 10−8–7.5 × 10−4 M | [ |
| QDs-SPE | AuNPs | AuNPs@CNOs/Chitosan | High ECL, increased effective surface area, high anti-β2M binding, enhanced photons capture, high detection limit, wide linear range, long-term stability and good selectivity | Label-free | Beta-2 microglobulin (β2M) | 1 fg mL−1 | 1 fg mL−1–100 ng mL−1 | [ |
| GCE | AuNPs | MWCNTs-Au | Signal amplification, sensitivity, selectivity, reproducibility, stability and low cost | Direct | Bisphenol A | 0.083 μM | 0.25–100 μM | [ |
| GCE | AuNPs | Au@BSA nanoparticles | Large surface area, biocompatibility, specificity, stability, reproducibility, favorable selectivity, wide dynamic range and an ultralow detection limit | Label-free | CEACEA) | 0.0003 ng mL−1 | 0.001–200 ng mL−1 | [ |
| GCE | AuNPs | AuNPs/ion liquid/hollowed TiO2 nano-shell | Specificity, repeatability, stability, storage, reproducibility, recovery for real sample test, ultralow detection limit, wide linear range, reliability, low-cost and on-site monitoring | Enzymatic | Cholesterol | 6.30 × 10−9 M | 8.33 × 10−9–4.17 × 10−7 M | [ |
| GCE | AuNPs | NPCo/Co3O4–Au | Stability, reproducibility and immobilization of large amount of biomolecules | Label-free | DON | 1 pg mL−1 | 5 pg mL−1–100 ng mL−1 | [ |
| GCE | AuNPs | MWCNTs-GO-Thi-Au | Enhanced ECL signal, high sensitivity, good selectivity and stability | Enzymatic | Cholesterol | 50 nM | 0.15–828 µM | [ |
| GCE | AuNPs | KNbO3-AuNPs@Bi2S3 | Strong ECL signal, sensitivity, stability, long-term stability, acceptable selectivity, precision and accuracy | Label-free | PSA | 3 pg mL−1 | 0.0055 ng mL−1 | [ |
| GCE | AuNPs | GO/MWCNTs-COOH/Au@CeO2 | High sensitivity, repeatability, selectivity, long-term stability, wide linear range | Label-free | CEA | 0.02 ng mL−1 | 0.05–100 ng mL−1 | [ |
| GCE | AuNPs | AuNPs-CdSe QDs | Sensitivity, large surface area, rapid, acceptable precision, good stability, bioactivity and low-cost | Competitive | Phenylethanolamine A (PA) | 0.0047 ng mL−1 | 0.02 –50 ng mL−1 | [ |
| GCE | AuNP | rGO/MWCNTs/AuNPs | Enhanced ECL signal intensity, high sensitivity, good reproducibility, stability and repeatability | Direct | Dopamine (DA) | 0.067 µM | 0.20–70 µM | [ |
| GCE | AuNPs | AuNPs-CdSe QDs | Rapid and ultrasensitive, good stability, specificity and fabrication reproducibility | Competitive | Clenbuterol (CLB) | 0.0084 ng mL−1 | 0.02–50 ng mL−1 | [ |
| GCE | AuNPs | Fe3O4 (Au-FrGO) | Large ECL signal, surface area, biocompatibility, sensitive response, excellent stability, repeatability and selectivity | Label-free | CEA | 3.28 fg mL−1 | 0.01 pg mL−1–10 ng mL−1 | [ |
| GCE | AuNPs | petal-like CdS/AuNPs | high sensitivity, stability, good selectivity and wide linear range | Label-free | Immunoglobulin E | 8.0 × 10−14 M | 5.0 × 10−13–1.0 × 10−9 M | [ |
| ITO | Gold nanodots | ABEI/GNDs/chitosan/COOH-MWCNTs | Strong and stable ECL signal, selectivity, stable and reliable response, extremely high sensitivity, satisfactory recovery | Label-free | N-Terminal Pro-brain natriuretic peptide (NT-proBNP) | 3.86 fg mL−1 | 0.01–100 pg mL−1 | [ |
| GCE | AgNPs | luminol-AgNPs@OMC | Fast, sensitive, specific, stable and reliable | Label-free | Aflatoxin B1 (AFB1) | 50 fg mL−1 | 0.1 pg mL−1–50 ng mL−1 | [ |
| GCE | Au@Ag nanorods | Au and Ag Bimetallic | Catalytic, sensitive, stable, specific and reproducible | Label-free | CEA | 30 fg mL−1 | 0.1 pg mL−1–380 ng mL−1 | [ |
| GCE | nanoFe3O4 | nanoFe3O4@GO | Good conductivity, magnetism, stability, reproducibility and regeneration | Label-free | Carbohydrate antigen 19-9 (CA19-9) | 0.0005 U mL−1 | 0.001–5 U mL−1 | [ |
| GCE | Fe3O4 | Fe3O4 (Au-FrGO) | Large ECL signal, specific surface area, biocompatibility, sensitive response, excellent stability, repeatability and selectivity | Label-free | CEA | 3.28 fg mL−1 | 0.01 pg mL−1–10 ng mL−1 | [ |
| GCE | Fe3O4 | (RGO)/Fe3O4/CdSe | Sensitivity, excellent reproducibility and stability, wide linear range and high selectivity | Label-free | Interleukin-6 (IL-6) | 0.65 pg mL−1 | 0.002–20 ng mL−1 | [ |
| GCE | Fe3O4 | CdS-Fe3O4 | Sensitive response, wide linear range, low detection limit, rapid, specific, stable, reliable and ultrasensitive ECL | Label-free | Ochratoxin A (OTA) | 2 pg mL−1 | 0.01–100 ng mL−1 | [ |
| GCE | Magnetic nanofibers/CNHs | Magnetic nanofibers-Fe3O4 | Excellent electrical conductivity, large surface areas, variable porosity, amplified ECL, acceptable precision, reproducibility, biocompatibility, sensitivity, low detection limit and stability | Label-free | AFB1 | 0.02 ng mL−1 | 0.05–200 ng mL−1 | [ |
| Modified titanium ribbon | AuNCs | Au NCs/GR | High sensitivity, low detection limit, wide dynamic range, low toxicity, good regeneration and can be used with real samples | Direct | Pentachlorophenol (PCP) | 0.1 fM | 0.1 fM–0.1 nM | [ |
| GCE | AuNCs | lum-AuNCs | 100-folds enhancement of ECL, high specificity, good stability and potential clinical application | Direct | Alkaline phosphatase (ALP) | 0.1 nM | 0.3–12 nM | [ |
Figure 7AuNPs nanocomposite-based ECL nanobiosensors: (A) ECL nanobiosensor with gold functionalized nonporous CO/Co3O4. Reprinted from Ref. [14] with permission from Elsevier; (B) ECL nanobiosensor incorporating the nanocomposite of KNbO3-AuNPs@Bi2S3. Reprinted from Ref. [70] with permission from Elsevier; (C) ECL nanobiosensor utilizing the nanocomposite of Au@BSA. Reprinted from Ref. [67] with permission from Elsevier; and (D) ECL nanobiosensor with ABEI/GNDs/chitosan/COOH-MWCNTs. Reprinted from [71] with permission from the American Chemical Society.
Figure 8AgNPs nanocomposite-based ECL nanobiosensors: (A) ECL nanobiosensor with nanocomposite of luminol-AgNPs@OMC. Reprinted from Ref. [62] with permission from Elsevier; (B) ECL nanobiosensor with nanocomposite of NH4CoPO4/Au@Ag-luminol. Reprinted from Ref. [78] with permission from Springer; (C) ECL nanobiosensor with nanocomposite of nanoFe3O4@GO. Reprinted from Ref. [79] with permission from Elsevier; (D) ECL nanobiosensor with nanocomposite of Fe3O4-NFs. Reprinted from [81] with permission from Elsevier.
Quantum dots-based ECL nanobiosensors.
| Electrode | NMs/NSMs | Nanocomposites | Function | Assay Type | Bioanalyte | LOD | Range | Ref |
|---|---|---|---|---|---|---|---|---|
| GCE | CdS QDs | CdS-Fe3O4 | Ultrasensitive ECL detection, wide linear range, low detection limit, rapid, specific, stable and reliable | Label-free | OTA | 2 pg mL−1 | 0.01–100 ng mL−1 | [ |
| GCE | CdSe QDs | CdSe QDs/PICA-MWNT | Good biocompatibility, high ECL intensity, synergistic improvement of sensitivity, good selectivity and reproducibility | Label-free | Alpha-fetoprotein (AFP) | 0.4 pg mL−1 | 0.002–2000 ng mL−1 | [ |
| GCE | CdSe QDs | HCNTs-Polyallylamine hydrochloride (PAH)-CdSe QDs | Signal amplification, increased surface area | Direct | DA | 0.2 × 10−9 M | 1.0 × 10−9–2.0 × 10−5 M | [ |
| GCE | CdSe QDs | AuNPs-CdSe QDs | Electron transport accelerators, rapid, acceptable, precision, good stability, bioactivity, low-cost and lower detection limit | Competitive | PA | 0.0047 ng mL−1 | 0.02–50 ng mL−1 | [ |
| GCE | CdSe QDs | AuNPs-CdSe QDs | Rapid, ultrasensitive, stability, specificity, fabrication, reproducibility and sensitivity | Competitive | CLB | 0.0084 ng mL−1 | 0.02–50 ng mL−1 | [ |
| GCE | CdSe QDs | (RGO)/Fe3O4/CdSe | Sensitivity, stability, wide linear range, reproducibility and selectivity | Label-free | IL-6 | 0.65 pg mL−1 | 0.002–20 ng mL−1 | [ |
| GCE | CdTe QDs | Graphene nanosheets (GNs)/CdTe QDs | Sensitivity, selectivity, reproducibility and ideal stability | Enzymatic | organophosphate pesticides (OPs) | 0.06 ng mL−1 | 0.2–10 ng mL−1 | [ |
| Au/AgrGO | Graphene QDs | Graphene QDs | Ultrasensitive ECL, excellent electron conductivity, stability, sensitivity and repeatability | Label-free | PSA | 0.29 pg mL−1 | 1 pg mL−1–10 ng mL−1 | [ |
Figure 9Quantum dots nanocomposite based ECL nanobiosensors: (A) ECL nanobiosensor with nanocomposite of CdS-Fe3O4. Reprinted from Ref. [80] with permission from the Royal Society of Chemistry; (B) ECL nanobiosensor with nanocomposite of Au/AgrGO. Reprinted from Ref. [38] with permission from Nature.
CNMs-, CNSMs- and NCs-based nanobiosensors.
| Electrode | NMs/NSMs | NCs | Function | Assay type | Bioanalyte | LOD | Range | Ref |
|---|---|---|---|---|---|---|---|---|
| GCE | MWCNTs | MWCNTs-Cys-AuNPs | Signal amplification, reproducibility, stability, sensitivity and cost-effective | Direct | DPH | 6.7 × 10−9 M | 2 × 10−8–7.5 × 10−4 M | [ |
| GCE | MWCNTs | MWCNT-Pt-luminol | ECL signal, sensitivity, fast analysis, stability and specificity | Label-free | CA19-9 | 0.00004 U mL−1 | 0.0001–10.0 U mL−1 | [ |
| GCW | MWCNTs | MWCNTs-Au | Signal amplification, selectivity, stability and low-cost | Direct | Bisphenol A | 0.083 μM | 0.25–100 μM | [ |
| GCE | HCNTs | HCNTs-Polyallylamine hydrochloride (PAH)-CdSe QDs | Signal amplification, increased surface area, stability, sensitivity and excellent specificity | Direct | DA | 0.2 × 10−9 M | 1.0 × 10−9–2.0 × 10−5 M | [ |
| GCE | Magnetic nanofibers/CNHs | CNHs | Excellent electrical conductivity, biocompatibility, large surface areas, variable porosity, amplified ECL, large antibody, acceptable precision, low detection limit, reproducibility and stability | Label-free | AFB1 | 0.02 ng mL−1 | 0.05–200 ng mL−1 | [ |
| GCE | MWCNTs | MWCNT-Pt-luminol | ECL signal, fast analysis, stability, reproducibility and specificity | Label-free | CA19-9 | 0.00004 U mL−1 | 0.0001–10.0 U mL−1 | [ |
| GCE | MWCNTs | nanoCo-MWCNTs | Sensitivity, economical and practical applications | Direct | Glucose | 50 nM | 0.5–600 μM | [ |
| GCE | MWCNTs | MWCNTs-GO-Thi-Au | Enhancing ECL, high sensitivity and good selectivity | Enzymatic | Cholesterol | 50 nM | 0.15–828 µM | [ |
| GCE | MWCNTs | GO/MWCNTs-COOH/Au@CeO2 | High sensitivity, repeatability, accelerated electrons transfer, long-term stability and wide linear range | Label-free | CEA | 0.02 ng mL−1 | 0.05–100 ng mL−1 | [ |
| ITO | MWCNTs | ABEI/GNDs/chitosan/COOH-MWCNTs | Strong and stable ECL signal, selectivity, stability and extremely high sensitivity | Label-free | NT-proBNP | 3.86 fg mL−1 | 0.01–100 pg mL−1 | [ |
| GCE | MWCNTs | rGO/MWCNTs/AuNPs | Enhanced ECL signal intensity, high sensitivity, good reproducibility and repeatability | Direct | DA | 0.067 µM | 0.20–70 µM | [ |
| GCE | GO | MWCNTs-GO-Thi-Au | Enhanced ECL, high sensitivity and excellent stability | Enzymatic | Cholesterol | 50 nM | 0.15–828 µM | [ |
| GCE | GO | GO/MWCNTs-COOH/Au@CeO2 | High sensitivity, accelerated electron transfer, selectivity and wide linear range | Label-free | CEA | 0.02 ng mL−1 | 0.05–100 ng mL−1 | [ |
| GCE | GO | nanoFe3O4@GO | Good conductivity, magnetism, reproducibility and regeneration | Label-free | CA19-9 | 0.0005 U mL−1 | 0.001–5 U mL−1 | [ |
| GCE | rGO | rGO/MWCNTs/AuNPs | Enhanced ECL signal intensity, high sensitivity and repeatability | Direct | DA | 0.067 µM | 0.20–70 µM | [ |
| GCE | rGO | Fe3O4 (Au-FrGO) | Increased ECL, specific surface area, biocompatibility, sensitive response, excellent stability and selectivity | Label-free | CEA | 3.28 fg mL−1 | 0.01 pg mL−1–10 ng mL−1 | [ |
| GCE | rGO | (RGO)/Fe3O4/CdSe | Sensitivity, stability, excellent reproducibility and selectivity | Label-free | IL-6 | 0.65 pg mL−1 | 0.002–20 ng mL−1 | [ |
| GCE | GO | PtNFs/GO/GODx | High electrocatalytic activity, enhanced luminol ECL, reliability, high surface area, linear range and low detection limit | Direct | Glucose | 2.8 μM | 5–80 μM | [ |
| QDs-SPE | CNOs | AuNPs@CNOs | High ECL, increased effective surface area for capturing and binding of antibodies, improved electron transmission rate, enhanced photon capture and highly sensitive | Label-free | β2M | 1 fg mL−1 | 1 fg mL−1–100 ng mL−1 | [ |
| GCE | SWCNH | Aptamer/SWCNH | Quenching of ECL, sensitive, selective, simple, time-saving and cost-effective | Label-free | Adenosine triphosphate (ATP) | 1 nM | 5 nM–500 μM | [ |
| GCE | OMCs | luminol-AgNPs@OMC | Fast, sensitive, specific, stable and reliable | Label-free | AFB1 | 50 fg mL−1 | 0.1 pg mL−1–50 ng mL−1 | [ |
Figure 10Carbon nanocomposite-based ECL nanobiosensors: (A) ECL nanobiosensor with nanocomposite of Au-FrGO and CeO2@TiO2. Reprinted from Ref. [10] with permission from Elsevier; (B) ECL nanobiosensor with nanocomposite of (RGO)/Fe3O4/PDDA/CdSe. Reprinted from Ref. [9] with permission from Elsevier; (C) ECL nanobiosensor with nanocomposite of GO/MWCNTs-COOH/Au@CeO2. Reprinted from Ref. [68] with permission from the American Chemical Society; (D) ECL nanobiosensor with nanocomposite of AuNPs@CNOs-CS. Reprinted from Ref. [7] with permission from the Royal Society of Chemistry.
| R − e− | R | (oxidation at the electrode surface) | |
| R + e− | R | (reduction at the electrode surface) | |
| R | R + R* | (annihilation process/formation of excited state) | |
| R* | R + | (emission of light) |
| R − e− | R | (oxidation at the electrode surface) | |
| C − e− | C | (reduction at the electrode surface) | |
| C + C | R + C | (homogenous chemical reactions) | |
| C | *Cr | (homogenous chemical reactions) | |
| *Cr + R | R | (homogenous chemical reactions) | |
| R | R + R* | Or R | |
| R* | (emission of light) |
| R + e− | R | (reduction at the electrode surface) | |
| C + e− | C | (reduction at the electrode surface) | |
| R | R + C | (homogenous chemical reactions) | |
| C | *Co | (homogenous chemical reactions) | |
| *Co + R | R | (homogenous chemical reactions) | |
| R | R + R* | Or R | |
| R* | (emission of light) |